MedTrace Logo

iDropper Usability in Glaucoma

NCT02031380 · Status: WITHDRAWN · Phase: PHASE1 · Type: INTERVENTIONAL

Last updated 2015-12-08

No results posted yet for this study

Summary

The purpose of this study is to evaluate the usability of a medication management support system for glaucoma patients self-administering eye drops named iDropper. The iDropper system is a home-based ocular medication management system that reminds, instructs, dispenses, and records eye drop medication usage. The iDropper system will be evaluated among a cohort of glaucoma subjects self-administering eye drops for 4-weeks.

Conditions

  • Glaucoma, Open-Angle [C11.525.381.407]

Interventions

DEVICE

Open angle glaucoma - iDropper device

The iDropper system is an eye drop dispensing device and medication monitor designed to optimize adherence behaviors for glaucoma patients.

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Care Team Solutions

    lead INDUSTRY

Principal Investigators

  • Michael Bailey, PhD · Care Team Solutions

  • Steven Chalfin, MD · The University of Texas Health Science Center at San Antonio

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02031380 on ClinicalTrials.gov